title: Rheumatoid arthritis-associated polymorphisms are not protective against Alzheimer's disease.
abstract: BACKGROUND
  Rheumatoid arthritis (RA) and Alzheimer's disease (AD) are inversely associated. To test the hypothesis that genetic elements associated with increased RA risk are associated with decreased AD risk, we evaluated RA genetic risk factors recently identified in genome-wide association studies (GWAS) for their association with AD in a two-stage, case-control analysis.
  
  
  RESULTS
  In our Stage 1 analysis of ~800 AD and ~1,200 non-AD individuals, three of seventeen RA-associated SNPs were nominally associated with AD (p < 0.05) with one SNP, rs2837960, retaining significance after correction for multiple testing (p = 0.03). The rs2837960_G (minor) allele, which is associated with increased RA risk, was associated with increased AD risk. Analysis of these three SNPs in a Stage 2 population, consisting of ~1,100 AD and ~2,600 non-AD individuals, did not confirm their association with AD. Analysis of Stage 1 and 2 combined suggested that rs2837960 shows a trend for association with AD. When the Stage 2 population was age-matched for the Stage 1 population, rs2837960 exhibited a non-significant trend with AD. Combined analysis of Stage 1 and the age-matched Stage 2 subset showed a significant association of rs2837960 with AD (p = 0.002, OR 1.24) that retained significance following correction for age, sex and APOE (p = 0.02, OR = 1.20). Rs2837960 is near BACE2, which encodes an aspartic protease capable of processing the AD-associated amyloid precursor protein. Testing for an association between rs2837960 and the expression of BACE2 isoforms in human brain, we observed a trend between rs2837960 and the total expression of BACE2 and the expression of a BACE2 transcript lacking exon 7 (p = 0.07 and 0.10, respectively).
  
  
  CONCLUSIONS
  RA-associated SNPs are generally not associated with AD. Moreover, rs2837960_G is associated with increased risk of both RA and, in individuals less than 80 years of age, with AD. Overall, these results contest the hypothesis that genetic variants associated with RA confer protection against AD. Further investigation of rs2837960 is necessary to elucidate the mechanism by which rs2837960 contributes to both AD and RA risk, likely via modulation of BACE2 expression.
authors: Department of Physiology, Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA. steve.estus@uky.edu.
authors: Christopher R
authors: CR
authors: Simmons
authors: Fanggeng
authors: F
authors: Zou
authors: Steven G
authors: SG
authors: Younkin
authors: Steven
authors: S
authors: Estus
references: JAMA. 1997 Oct 22-29;278(16):1349-56
references: 9343467
references: Neuroreport. 2001 Jul 3;12(9):1799-802
references: 11435901
references: Nat Genet. 2008 Feb;40(2):124-5
references: 18227866
references: JAMA. 2010 May 12;303(18):1832-40
references: 20460622
references: Nature. 2007 Oct 18;449(7164):851-61
references: 17943122
references: PLoS One. 2008 Jan 23;3(1):e1475
references: 18213383
references: Nat Genet. 2007 Jan;39(1):17-23
references: 17192785
references: J Neuroinflammation. 2008 Oct 17;5:45
references: 18925972
references: Dement Geriatr Cogn Disord. 2009;27(1):59-68
references: 19141999
references: Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W273-9
references: 15215394
references: Neurology. 2008 Jun 10;70(24):2291-8
references: 18509093
references: Alzheimer Dis Assoc Disord. 2005 Apr-Jun;19(2):55-66
references: 15942322
references: Nature. 2001 Nov 8;414(6860):212-6
references: 11700559
references: PLoS Biol. 2008 Dec 23;6(12):e1
references: 19222302
references: Neurobiol Aging. 2000 May-Jun;21(3):383-421
references: 10858586
references: Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
references: 12184808
references: J Clin Invest. 2003 Aug;112(3):440-9
references: 12897211
references: Brain Res. 2009 Feb 27;1257:10-5
references: 19124009
references: BMC Mol Biol. 2005 Feb 18;6:4
references: 15720708
references: Am J Med Genet B Neuropsychiatr Genet. 2003 May 15;119B(1):44-7
references: 12707937
references: Neurology. 2009 Jun 2;72(22):1899-905
references: 19386997
references: Immunology. 2010 Feb;129(2):154-69
references: 20561356
references: Neurology. 2008 Jan 1;70(1):17-24
references: 18003940
references: BMC Genomics. 2008 Jan 25;9:41
references: 18221515
references: Arch Neurol. 2010 Aug;67(8):961-4
references: 20554627
references: Hum Mol Genet. 2007 Jul 15;16(14):1765-72
references: 17517690
references: Hum Mol Genet. 2008 Apr 1;17(7):929-35
references: 18065781
references: Nucleic Acids Res. 2003 Jul 1;31(13):3651-3
references: 12824386
references: J Neurol Sci. 2005 Sep 15;236(1-2):17-24
references: 16023140
references: Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9712-7
references: 10931940
references: FASEB J. 2005 May;19(7):739-49
references: 15857888
references: Br J Rheumatol. 1994 May;33(5):501-2
references: 8173862
references: J Biol Chem. 2005 Sep 2;280(35):30797-806
references: 15987683
references: Bioinformatics. 2008 Dec 15;24(24):2938-9
references: 18974171
references: Bioinformatics. 2002 Feb;18(2):333-4
references: 11847087
references: Neurology. 1994 Feb;44(2):227-32
references: 8309563
references: Eur J Neurosci. 2011 Jan;33(2):236-43
references: 21073551
references: Br J Rheumatol. 1989 Feb;28(1):86-8
references: 2917245
references: J Mol Neurosci. 2006;29(1):65-80
references: 16757811
references: Lancet. 2010 Sep 25;376(9746):1094-108
references: 20870100
references: J Neurochem. 2010 Feb;112(4):1045-53
references: 19968762
references: Neurobiol Aging. 2000 May-Jun;21(3):447-8; discussion 451-3
references: 10858592
references: Neuron. 2007 Jun 7;54(5):713-20
references: 17553421
references: JAMA. 2003 Jun 4;289(21):2819-26
references: 12783912
references: Am J Med Genet B Neuropsychiatr Genet. 2010 Jul;153B(5):1060-9
references: 20468060
references: Neurology. 1993 Aug;43(8):1609-11
references: 8351023
references: Cytogenet Cell Genet. 2000;89(3-4):177-84
references: 10965118
references: Nat Rev Neurol. 2010 Apr;6(4):193-201
references: 20234358
references: Nat Genet. 2009 Feb;41(2):192-8
references: 19136949
references: Am J Hum Genet. 2007 Sep;81(3):559-75
references: 17701901
references: Arch Neurol. 2008 Jan;65(1):45-53
references: 17998437
references: Nat Med. 2007 Apr;13(4):408-9
references: 17415372
references: Mt Sinai J Med. 2010 Jan-Feb;77(1):50-8
references: 20101714
references: J Neurochem. 2005 May;93(4):1038-46
references: 15857407
references: J Neurochem. 2010 Nov;115(3):614-24
references: 20807319
references: Nat Med. 2007 Apr;13(4):432-8
references: 17351623
references: Arch Gen Psychiatry. 2006 Feb;63(2):168-74
references: 16461860
references: J Mol Neurosci. 2006;29(1):81-99
references: 16757812
references: Lancet. 1990 Apr 28;335(8696):1037
references: 1970087
references: Neurology. 2002 Sep 24;59(6):880-6
references: 12297571
references: J Alzheimers Dis. 2010;19(1):355-61
references: 20061650
references: J Neuroimmunol. 2010 Jul 27;224(1-2):93-100
references: 20681057
references: Hum Mutat. 2010 Jun;31(6):702-9
references: 20232416
references: FEBS Lett. 2006 Dec 11;580(28-29):6550-60
references: 17113083
references: Neurology. 2010 Sep 28;75(13):1203-10
references: 20811000